Content about Pharmaceutical drug

September 10, 2012

A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

CAMBRIDGE, Mass. — A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

AstraZeneca and the Broad Institute, owned jointly by Harvard University and MIT, announced Monday that they would collaborate for two years to develop medicines to treat severe infections, saying the identification of high-quality chemicals for the development of new drugs was a significant challenge. The two will use the Broad Institute's collection of 100,000 chemicals known as diversity-oriented synthesis, or DOS compounds.

September 4, 2012

In what could symbolize the so-called "patent cliff" that an executive from healthcare market research firm IMS Health spoke of at a recent trade show, a regional mass merchandise chain is taking what used to be the world's top-selling drug and giving it away for free.

GRAND RAPIDS, Mich. — In what could symbolize the so-called "patent cliff" that an executive from healthcare market research firm IMS Health spoke of at a recent trade show, a regional mass merchandise chain is taking what used to be the world's top-selling drug and giving it away for free.

August 23, 2012

Thrifty White Pharmacy has announced the introduction of the Rx Timer Cap, which it is giving away for free to each pharmacy patient who enrolls in the Ready Refill or Medication Synchronization programs.

PLYMOUTH, Minn. — Thrifty White Pharmacy — which operates more than 80 locations in Minnesota, North Dakota, South Dakota, Iowa, Montana and Wisconsin — has announced the introduction of the Rx Timer Cap, which it is giving away for free to each pharmacy patient who enrolls in the Ready Refill or Medication Synchronization programs. Additional Rx Timer Caps may be purchased at any Thrifty White location.

August 9, 2012

AstraZeneca paid $3.2 billion to Amylin Pharmaceuticals Thursday following the latter's acquisition by Bristol-Myers Squibb, AstraZeneca and Bristol said.

PRINCETON, N.J. — AstraZeneca paid $3.2 billion to Amylin Pharmaceuticals Thursday following the latter's acquisition by Bristol-Myers Squibb, AstraZeneca and Bristol said.

The payment was made as part of the expansion of a deal between the drug manufacturers made in 2007 to develop diabetes drugs. Bristol announced Wednesday that it had completed its acquisition of Amylin, making the San Diego-based drug maker a wholly owned subsidiary.

August 6, 2012

Winn-Dixie announced the generic form of Plavix (clopidogrel) now is available for $4 for 30-day and $10 for 90-day prescriptions as part of the company's prescription savings program.

JACKSONVILLE, Fla. — Winn-Dixie announced the generic form of Plavix (clopidogrel) now is available for $4 for 30-day and $10 for 90-day prescriptions as part of the company's prescription savings program.

Winn-Dixie recently launched a prescription savings program in all of its pharmacies that offers deep discounts on more than 400 generic medications and varied discounts on branded and other generic medication.

August 1, 2012

The Food and Drug Administration has approved a generic drug designed to treat asthma in children.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic drug designed to treat asthma in children.

Watson Pharmaceuticals announced Wednesday the approval of budesonide inhalation suspension in the 0.25-mg/2-mL and 0.5-mg/2-mL strengths. The drug is used to control and prevent asthma symptoms in children ages 12 months to 8 years.

The drug is a generic version of AstraZeneca's Pulmicort Respules, which had sales of $1.1 billion during the 12-month period ended in May.

July 25, 2012

A subsidiary of Johnson & Johnson has launched a mobile medication adherence application that it said can be used for any prescription or over-the-counter medication or supplement.

SAN DIEGO — A subsidiary of Johnson & Johnson has launched a mobile medication adherence application that it said can be used for any prescription or over-the-counter medication or supplement.

Janssen Healthcare Innovation, a unit of Janssen Research & Development announced Wednesday the launch of Care4Today Mobile Adherence, a secure messaging platform available for iPhone, Android and BlackBerry devices, among others.

July 10, 2012

President Barack Obama signed into law Monday what some called a "historic" reauthorization of the Prescription Drug User Fee Act.

WASHINGTON — President Barack Obama signed into law Monday what some called a "historic" reauthorization of the Prescription Drug User Fee Act.

July 2, 2012

Bristol-Myers Squibb is acquiring Amylin Pharmaceuticals, the drug maker said Friday.

NEW YORK — Bristol-Myers Squibb is acquiring Amylin Pharmaceuticals, the drug maker said Friday.

Bristol announced that it would acquire Amylin for $5.3 billion, or $31 per share. The total value of the acquisition is about $7 billion, including $1.7 billion in Amylin's contractual payment and debt obligations.

June 21, 2012

In 2008, an investigation by the Associated Press revealed that drinking water supplies in major cities and metropolitan regions across the country are riddled with pharmaceutical compounds.

In 2008, an investigation by the Associated Press revealed that drinking water supplies in major cities and metropolitan regions across the country are riddled with pharmaceutical compounds. For 41 million Americans, it suggests water with something extra means more than just a slice of lemon, though the quantities of pharmaceutical compounds in the water are too small to constitute a medical dose, according to the report.


June 19, 2012

AstraZeneca and Rigel Pharmaceuticals have entered an exclusive worldwide license agreement for the global development and commercialization of an investigational treatment for moderate to severe chronic asthma.

SOUTH SAN FRANCISCO, Calif. — AstraZeneca and Rigel Pharmaceuticals have entered an exclusive worldwide license agreement for the global development and commercialization of an investigational treatment for moderate to severe chronic asthma.

May 24, 2012

Following the Senate’s defeat of a proposal that would have permitted “personal importation” of prescription drug medications, the National Association of Chain Drug Stores lauded the Senate’s decision to support patient safety.

ALEXANDRIA, Va. — Following the Senate’s defeat of a proposal that would have permitted “personal importation” of prescription drug medications, the National Association of Chain Drug Stores lauded the Senate’s decision to support patient safety.

May 24, 2012

Rexam Prescription Products recently partnered with Marsh and MainStreet Market pharmacies for a new campaign that encourages consumers to safely dispose of their unused or expired medications.

PERRYSBURG, Ohio — Rexam Prescription Products recently partnered with Marsh and MainStreet Market pharmacies for a new campaign that encourages consumers to safely dispose of their unused or expired medications.

May 23, 2012

Pfizer has partnered with EatingWell magazine to launch the drug maker's Lipitor For You "Recipes 2 Go" mobile application.

NEW YORK — Pfizer has partnered with EatingWell magazine to launch the drug maker's Lipitor For You "Recipes 2 Go" mobile application.

May 17, 2012

The Food and Drug Administration has approved generic versions of one of the country's top-selling drugs made by eight different companies, the agency said Thursday.

SILVER SPRING, Md. — The Food and Drug Administration has approved generic versions of one of the country's top-selling drugs made by eight different companies, the agency said Thursday.

May 16, 2012

Walmart and Sam's Club will be among the first retailers to offer a generic version of an antiplatelet drug.

BENTONVILLE, Ark. — Walmart and Sam's Club will be among the first retailers to offer a generic version of an antiplatelet drug.

Clopidogrel, the generic version of Plavix, will be available at both banners pharmacies on May 19. The patent for the Bristol-Myers Squibb/Sanofi drug officially expires Thursday.

May 2, 2012

CVS Caremark announced on Wednesday that it is supporting Million Hearts during National High Blood Pressure Education Month in May through a number of patient-focused initiatives.

WOONSOCKET, R.I. — CVS Caremark announced on Wednesday that it is supporting Million Hearts during National High Blood Pressure Education Month in May through a number of patient-focused initiatives.

Launched by the Department of Health and Human Services and led by the Centers for Disease Control and Prevention and Centers for Medicare and Medicaid Services, Million Hearts is a national initiative to prevent 1 million heart attacks and strokes in the United States over the next five years.

April 19, 2012

The study's findings that the Part D coverage gap — or “doughnut hole” — led to a significant gap in the adherence of cardiovascular medications may not come as a complete surprise; however, it undoubtedly underscores the important role that pharmacy can play in helping patients navigate plan strategies that promote the use of lower-cost medications.

WHAT IT MEANS AND WHY IT'S IMPORTANT — The study's findings that the Part D coverage gap — or “doughnut hole” — led to a significant gap in the adherence of cardiovascular medications may not come as a complete surprise; however, it undoubtedly underscores the important role that pharmacy can play in helping patients navigate plan strategies that promote the use of lower-cost medications.

April 17, 2012

Workers' compensation pharmacy costs took on an extra $2.1 billion in 2011 due to unnecessary use of more expensive drugs, according to a new report by pharmacy benefit manager Express Scripts.

ST. LOUIS — Workers' compensation pharmacy costs took on an extra $2.1 billion in 2011 due to unnecessary use of more expensive drugs, according to a new report by pharmacy benefit manager Express Scripts.

April 17, 2012

Medicare Part D beneficiaries with cardiovascular conditions who had no financial assistance during the "doughnut hole" coverage gap were 57% more likely to discontinue their cardiovascular medications than those beneficiaries who had consistent drug coverage, according to a study conducted by researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.

WOONSOCKET, R.I. — Medicare Part D beneficiaries with cardiovascular conditions who had no financial assistance during the "doughnut hole" coverage gap were 57% more likely to discontinue their cardiovascular medications than those beneficiaries who had consistent drug coverage, according to a study conducted by researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.

April 13, 2012

Drug companies invested nearly $50 billion in research and development in 2011, according to a new report by a drug industry trade group.

WASHINGTON — Drug companies invested nearly $50 billion in research and development in 2011, according to a new report by a drug industry trade group.

April 10, 2012

Rite Aid is offering personalized reports designed to increase medication adherence, the company said Tuesday.

CAMP HILL, Pa. — Rite Aid is offering personalized reports designed to increase medication adherence, the company said Tuesday.

March 29, 2012

The U.S. over-the-counter drug market saw strong growth in 2011, thanks to switches of prescription drugs to OTC, gains in the allergy relief products category and holistic marketing, according to a new report from Kline.

PARSIPPANY, N.J. — The U.S. over-the-counter drug market saw strong growth in 2011, thanks to switches of prescription drugs to OTC, gains in the allergy relief products category and holistic marketing, according to a new report from Kline.

According to the international consulting and research firm's Nonprescription Drugs USA 2011 report, at the manufacturers' level, the U.S. OTC drug market posted a gain of 2.4%, reaching $21.4 billion in 2011.

March 26, 2012

The recent Food and Drug Administration public meeting on driving future switch potential by way of the pharmacist and/or health technology sparked some discussion on what’s next.


The recent Food and Drug Administration public meeting on driving future switch potential by way of the pharmacist and/or health technology sparked some discussion on what’s next.


March 19, 2012

The National Community Pharmacists Association has applauded a member of its organization for participating in the organization's drug disposal program.

ALEXANDRIA, Va. — The National Community Pharmacists Association has applauded a member of its organization for participating in the organization's drug disposal program.